Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Johnson and Johnson
Fish and Richardson
Citi
Medtronic
QuintilesIMS
Moodys
Dow
Healthtrust
Cerilliant

Generated: January 22, 2018

DrugPatentWatch Database Preview

Aspirin; dipyridamole - Generic Drug Details

« Back to Dashboard

What are the generic sources for aspirin; dipyridamole and what is the scope of aspirin; dipyridamole patent protection?

Aspirin; dipyridamole
is the generic ingredient in two branded drugs marketed by Boehringer Ingelheim, Amneal Pharms, Barr, Impax Labs Inc, Par Pharm Inc, Sandoz Inc, and Zydus Pharms Usa Inc, and is included in seven NDAs. There is one patent protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Aspirin; dipyridamole has thirty-two patent family members in twenty-four countries.

There are twenty-one drug master file entries for aspirin; dipyridamole. Thirteen suppliers are listed for this compound.
Summary for aspirin; dipyridamole

US Patents and Regulatory Information for aspirin; dipyridamole

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Par Pharm Inc ASPIRIN AND DIPYRIDAMOLE aspirin; dipyridamole CAPSULE, EXTENDED RELEASE;ORAL 207944-001 Jan 18, 2017 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Barr ASPIRIN AND DIPYRIDAMOLE aspirin; dipyridamole CAPSULE, EXTENDED RELEASE;ORAL 078804-001 Aug 14, 2009 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Impax Labs Inc ASPIRIN AND DIPYRIDAMOLE aspirin; dipyridamole CAPSULE, EXTENDED RELEASE;ORAL 206964-001 Jan 18, 2017 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Boehringer Ingelheim AGGRENOX aspirin; dipyridamole CAPSULE, EXTENDED RELEASE;ORAL 020884-001 Nov 22, 1999 AB RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Amneal Pharms ASPIRIN AND DIPYRIDAMOLE aspirin; dipyridamole CAPSULE, EXTENDED RELEASE;ORAL 206392-001 Mar 8, 2016 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz Inc ASPIRIN AND DIPYRIDAMOLE aspirin; dipyridamole CAPSULE, EXTENDED RELEASE;ORAL 206739-001 Jan 18, 2017 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Zydus Pharms Usa Inc ASPIRIN AND DIPYRIDAMOLE aspirin; dipyridamole CAPSULE, EXTENDED RELEASE;ORAL 206753-001 Aug 29, 2017 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for aspirin; dipyridamole

Supplementary Protection Certificates for aspirin; dipyridamole

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
/1999 Austria ➤ Subscribe PRODUCT NAME: DIPYRIDAMOL IN KOMBINATION MIT ACETYLSALICYLSAEURE; NAT. REGISTRATION NO/DATE: 1-22779 19981112; FIRST REGISTRATION: FR NL 22160 19970709
C/GB98/043 United Kingdom ➤ Subscribe PRODUCT NAME: DIPYRIDAMOLE, OPTIONALLY IN THE FORM OF A PHYSIOLOGICALLY ACCEPTABLE SALT, AND O-ACETYLSALICYLIC ACID, OPTIONALLY IN THE FORM OF A PHYSIOLOGICALLY SALT, I.E. ASASANTIN RETARD; REGISTERED: FR NL 22160 19970709; UK 00015/0224 19980512
90001 Netherlands ➤ Subscribe PRODUCT NAME: DIPYRIDAMOL, DESGEWENST IN DE VORM VAN EEN FYSIOLOGISCH AAN- VAARDBAAR ZOUT, EN ACETYLSALICYLZUUR, DESGEWENST IN DE VORM VAN EEN FYSIOLOGISCH AANVAARDBAAR ZOUT,IN EEN GEWICHTSVERHOUDING TUSSEN DIPYRIDAMOL-BESTANDDEEL EN ACETYLSALICYLZUUR-BESTANDDE; NAT. REGISTRATION NO/DATE: RVG 21171 19980713; FIRST REGISTRATION: FR 343 234.9, 560 483.7 19970709
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
US Army
Teva
McKesson
Cantor Fitzgerald
Mallinckrodt
US Department of Justice
Accenture
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot